Jiang Cui, MD
Clinical Cardiac Electrophysiology · Germantown, TNNPI 1447331152
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (48.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Medtronic at 33.1% of the total. 2025 is the largest year on record at $5,858, 2.6 times the $2,215 reported in 2019. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in TN, where the typical reported total is $12,690.
Across 234 payments — averaging $61.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abbott$3K
- Boston Scientific$2K
- Biosense Webster, Inc.$1K
- Medical Device Business Services, Inc.$1K
- Impulse Dynamics (USA) Inc.$335
- plus $2K from 21 others
What the payments were for
- Consulting fees$9006%
- Travel & lodging$6,88848%
- Food & beverage$6,57346%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 41 | $4,758 |
| Abbott | 37 | $3,497 |
| Boston Scientific | 19 | $1,602 |
| Biosense Webster, Inc. | 10 | $1,382 |
| Medical Device Business Services, Inc. | 26 | $1,002 |
| Impulse Dynamics (USA) Inc. | 4 | $335 |
| Novartis | 18 | $292 |
| Philips North America LLC | 17 | $287 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $231 |
| E.r. Squibb & Sons, L.L.C. | 11 | $181 |
| Bardy Diagnostics, Inc. | 3 | $157 |
| Amarin Pharma, Inc. | 6 | $119 |
| AstraZeneca | 5 | $67 |
| Cvrx, Inc. | 1 | $57 |
| Pfizer | 4 | $52 |
| Johnson & Johnson | 4 | $50 |
| Amgen | 3 | $45 |
| Sanofi-aventis U.S. LLC | 3 | $43 |
| Merck | 2 | $34 |
| Actelion Pharmaceuticals US, Inc. | 3 | $33 |
| Lundbeck LLC | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 1 | $28 |
| Biotronik Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $16 |
| Atricure, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Chiesi USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$1,741
- AVEIR$1,508
- Watchman$1,211
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$1,049
- EVERA MRI XT DR SURESCAN$1,012
- OPTIMIZER$432
- QDOT MICRO Catheter$264
- AURORA EV-ICD MRI SURESCAN$235
- Arctic Front$174
- Carnation Ambulatory Monitor$125
- LifeVest$100
How this compares
$14,361 in reported general payments places this provider in the 50th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
See all clinical cardiac electrophysiology providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 607 | $518,112 |
| XareltoRivaroxaban | 109 | $131,306 |
| EntrestoSacubitril/Valsartan | 110 | $116,385 |
| JardianceEmpagliflozin | 46 | $50,469 |
| FarxigaDapagliflozin Propanediol | 31 | $27,728 |
| BrilintaTicagrelor | 17 | $15,594 |
| Repatha SureclickEvolocumab | 14 | $12,965 |
| Flecainide Acetate | 225 | $7,826 |
| Amiodarone Hcl | 316 | $5,142 |
| Midodrine Hcl | 45 | $2,432 |
| Carvedilol | 379 | $2,267 |
| Atorvastatin Calcium | 243 | $1,700 |
| Potassium Chloride | 90 | $1,647 |
| Valsartan | 73 | $1,539 |
| Metoprolol Tartrate | 257 | $1,448 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $52 | $518,112607 claims |
| Johnson & JohnsonXarelto | $50 | $131,306109 claims |
| NovartisEntresto | $292 | $116,385110 claims |
| Boehringer IngelheimJardiance | $14 | $50,46946 claims |
| AstraZenecaFarxiga, Brilinta | $67 | $43,32248 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
Other clinical cardiac electrophysiology in Germantown
- David LanGermantown$134K
- Christopher IngelmoGermantown$31K
- James LitzowGermantown$10K
- Stephen FahrigNashville$605K
- Gregory BashianNashville$361K
- Harish ManyamChattanooga$265K
- William StevensonNashville$172K
- Sandeep DuggalNashville$151K
- Sean WhalenNashville$149K
- Harikrishna TandriNashville$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.